Status:
COMPLETED
Study to Assess the Incidence of Intussusception in Children < 2 Years of Age in Singapore
Lead Sponsor:
GlaxoSmithKline
Conditions:
Intussusception
Eligibility:
All Genders
Up to 24 years
Brief Summary
This prospective study aims to estimate the incidence of intussusception among children \< 2 years old through hospital-based surveillance in Singapore.
Eligibility Criteria
Inclusion
- A male or female infant aged \< 24months at the time of diagnosis of intussusception.
- Subject is diagnosed with definite, probable, possible, suspected intussusception during the period of at least one year beginning at study start.
- Written informed consent obtained from the parent or guardian of the subject.
Exclusion
- A male or female infant ≥ 24 months of age at the time of intussusception diagnosis.
- The subject has had a radiographically or surgically confirmed case of intussusception prior to the current episode.
Key Trial Info
Start Date :
May 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
178 Patients enrolled
Trial Details
Trial ID
NCT01177839
Start Date
May 1 2002
End Date
July 1 2010
Last Update
November 22 2012
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Singapore, Singapore, 119074
2
GSK Investigational Site
Singapore, Singapore, 169608
3
GSK Investigational Site
Singapore, Singapore, 228510
4
GSK Investigational Site
Singapore, Singapore, 229899